Chesterfield Technology Company Reaches 50th Issued Patent
November 1, 2016
Katalyst™ Surgical Continues to Grow and Innovate in Surgical Instrument Field
CHESTERFIELD, Mo. (Nov. 1, 2016) – Katalyst Surgical, LLC, a Chesterfield-based ophthalmic surgical instrument research and development company, celebrates its 50 th issued patent in just six years of operation on November 1, 2016.
Since obtaining a loan through the Missouri Technology Corporation in 2011 to boost Missouri job creation in technology, the company has grown from just 15 employees to almost 80, and offers thousands of products, many of which have patents or patents pending on their innovative designs. This is Katalyst's 30 th patent this year as well.
"We're excited to celebrate this milestone as a company and as a community. We aim to invent and move the industry forward, and it's all the more rewarding knowing we have brought jobs to Chesterfield and Missouri at the same time," said Gregg Scheller, founder and CEO Katalyst Surgical, LLC.
Katalyst Surgical's latest patents are for its Steerable™ laser probe. This cutting-edge instrument is a fiber optic laser delivery accessory used in ophthalmic surgery to treat the retina. The novelty of the device is in the tip, where a tube is fashioned to allow the surgeon the opportunity to steer and point the tip at different areas in the eye. By "steering" the tip, the surgeon can apply laser energy, even at the probe entry site. This is the most patented device ever on the market for performing this function.
"It's fitting that our 50th patent is on the Steerable. This is something we've put a lot of time and effort into developing, and we're not done," said Scheller.
Katalyst Surgical recently returned from showcasing their latest models at the American Academy of Ophthalmology Annual Meeting in Chicago. The team continues to travel all over the world to bring their instruments to new places, and work with surgeons to create new products.
"Our aim is to design instruments to solve problems and help surgeons accomplish their objectives. If our tool can help save someone's sight, that's what makes all our work worthwhile," he said.
Scheller said that Katalyst continues to grow their business and their team regularly. He hopes to continue working to create new instruments, and is optimistic a 100 th patent will be right around the corner. Since its inception, Katalyst has filed for more than 115 patents and intends to continue to change the landscape of ophthalmic surgery.
About Katalyst™ Surgical: Katalyst Surgical, LLC invents, develops, and manufactures ophthalmic surgical instruments for use all around the world. It specializes in disposable and reusable instruments that offer precision and control at an affordable price for surgeons and hospitals. The company was founded in 2010 by Gregg Scheller, former founder and CEO of Synergetics®, which he took from a small operation in his garage to a NASDAQ listing. Scheller is an inventor that currently has 96 issued patents and more than 130 pending patents.